Yield10 Bioscience (YTEN) Competitors $0.57 +0.01 (+1.79%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends YTEN vs. IVP, EDBL, AAGRW, AAGR, CEADW, EDBLW, KALWW, YOTAW, YOTAR, and CTVAShould you be buying Yield10 Bioscience stock or one of its competitors? The main competitors of Yield10 Bioscience include Inspire Veterinary Partners (IVP), Edible Garden (EDBL), African Agriculture (AAGRW), African Agriculture (AAGR), CEA Industries (CEADW), Edible Garden (EDBLW), Kalera Public (KALWW), Yotta Acquisition (YOTAW), Yotta Acquisition (YOTAR), and Corteva (CTVA). These companies are all part of the "agriculture" industry. Yield10 Bioscience vs. Inspire Veterinary Partners Edible Garden African Agriculture African Agriculture CEA Industries Edible Garden Kalera Public Yotta Acquisition Yotta Acquisition Corteva Inspire Veterinary Partners (NASDAQ:IVP) and Yield10 Bioscience (NASDAQ:YTEN) are both small-cap consumer staples companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, media sentiment, community ranking, valuation, institutional ownership, earnings, profitability, risk and analyst recommendations. Do institutionals and insiders hold more shares of IVP or YTEN? 4.8% of Inspire Veterinary Partners shares are owned by institutional investors. Comparatively, 4.9% of Yield10 Bioscience shares are owned by institutional investors. 6.1% of Yield10 Bioscience shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has more volatility and risk, IVP or YTEN? Inspire Veterinary Partners has a beta of -2.87, meaning that its stock price is 387% less volatile than the S&P 500. Comparatively, Yield10 Bioscience has a beta of 1.35, meaning that its stock price is 35% more volatile than the S&P 500. Does the MarketBeat Community believe in IVP or YTEN? Yield10 Bioscience received 221 more outperform votes than Inspire Veterinary Partners when rated by MarketBeat users. CompanyUnderperformOutperformInspire Veterinary PartnersN/AN/AYield10 BioscienceOutperform Votes22160.55% Underperform Votes14439.45% Which has better earnings and valuation, IVP or YTEN? Yield10 Bioscience has lower revenue, but higher earnings than Inspire Veterinary Partners. Yield10 Bioscience is trading at a lower price-to-earnings ratio than Inspire Veterinary Partners, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInspire Veterinary Partners$16.67M0.05-$14.79M-$169.670.00Yield10 Bioscience$60K6.33-$14.45M-$26.12-0.02 Do analysts prefer IVP or YTEN? Yield10 Bioscience has a consensus price target of $96.00, indicating a potential upside of 16,742.11%. Given Yield10 Bioscience's higher probable upside, analysts plainly believe Yield10 Bioscience is more favorable than Inspire Veterinary Partners.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inspire Veterinary Partners 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AYield10 Bioscience 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Is IVP or YTEN more profitable? Yield10 Bioscience has a net margin of 0.00% compared to Inspire Veterinary Partners' net margin of -109.98%. Yield10 Bioscience's return on equity of 0.00% beat Inspire Veterinary Partners' return on equity.Company Net Margins Return on Equity Return on Assets Inspire Veterinary Partners-109.98% -3,040.29% -81.32% Yield10 Bioscience N/A N/A -296.08% Does the media favor IVP or YTEN? In the previous week, Inspire Veterinary Partners had 2 more articles in the media than Yield10 Bioscience. MarketBeat recorded 2 mentions for Inspire Veterinary Partners and 0 mentions for Yield10 Bioscience. Inspire Veterinary Partners' average media sentiment score of 0.25 beat Yield10 Bioscience's score of 0.00 indicating that Inspire Veterinary Partners is being referred to more favorably in the media. Company Overall Sentiment Inspire Veterinary Partners Neutral Yield10 Bioscience Neutral SummaryYield10 Bioscience beats Inspire Veterinary Partners on 11 of the 16 factors compared between the two stocks. Ad Porter & CompanyTrue paradigm shiftI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. Get Yield10 Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for YTEN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart YTEN vs. The Competition Export to ExcelMetricYield10 BioscienceAgricultural production IndustryStaples SectorNASDAQ ExchangeMarket Cap$380,000.00$1.96B$15.09B$8.53BDividend YieldN/A2.60%2.62%4.14%P/E Ratio-0.029.5417.9615.14Price / Sales6.331.864.3793.53Price / CashN/A54.8420.8534.04Price / Book-0.111.365.815.01Net Income-$14.45M$7.81M$576.14M$225.46M7 Day Performance-34.85%-6.28%-1.39%0.37%1 Month Performance-45.71%-8.56%-2.72%3.57%1 Year Performance-92.34%-7.64%10.87%29.42% Yield10 Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)YTENYield10 BioscienceN/A$0.57+1.8%$96.00+16,742.1%-92.2%$380,000.00$60,000.00-0.0230Gap UpIVPInspire Veterinary Partners0.3368 of 5 stars$0.28flatN/A-99.6%$1M$16.67M0.00156EDBLEdible Garden0.4872 of 5 stars$0.14flatN/A-98.8%$80,000.00$14.05M0.0050News CoverageGap DownAAGRWAfrican AgricultureN/AN/AN/AN/A$0.00$1.75M0.0085AAGRAfrican AgricultureN/A$0.00flatN/AN/A$0.00$1.82M0.004News CoverageCEADWCEA IndustriesN/A$0.01flatN/AN/A$0.00$3.16M0.0030Positive NewsEDBLWEdible GardenN/A$0.02flatN/A-45.1%$0.00$14.77M0.0050KALWWKalera PublicN/AN/AN/AN/A$0.00$5.67M0.002YOTAWYotta AcquisitionN/A$0.03flatN/AN/A$0.00N/A0.00N/APositive NewsYOTARYotta AcquisitionN/A$0.13flatN/A-13.0%$0.00N/A0.002Positive NewsCTVACorteva4.0564 of 5 stars$60.92-1.1%$62.84+3.2%+27.5%$42.62B$17.23B46.8622,500Upcoming EarningsDividend AnnouncementShort Interest ↓ Related Companies and Tools Related Companies IVP Competitors EDBL Competitors AAGRW Competitors AAGR Competitors CEADW Competitors EDBLW Competitors KALWW Competitors YOTAW Competitors YOTAR Competitors CTVA Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:YTEN) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Yield10 Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Yield10 Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
